Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.
EC grants conditional approval for Pfizer’s haemophilia B therapy
The conditional marketing authorisation for Pfizer’s DURVEQTIX is valid across the 27 EU member states, Iceland, Liechtenstein and Norway. Credit: YES Market Media / Shutterstock.
July 26, 2024